Announce Date | 01/29/2025 |
EPS Normalized Actual | $0.71 (Beat by $0.02) |
EPS GAAP Actual | $0.71 (Beat by $0.02) |
Revenue Actual | $4.229B |
Revenue Surprise | Beat by $4229M |
Announce Date | 03/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.5776 |
EPS GAAP Estimate | $0.5776 |
Revenue Estimate | $3.8627222B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 3.65 | 4.46 | 3.53134 | 3.79765 | 1 |
Dec 2027 | 3 | 5.43 | 2.90633 | 3.06595 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.19 | -0.81708 | 4.229B | -5.39% | 220.2M |
FQ3 2024 (Sep 2024) | -0.39 | -0.97268 | 4.332B | 11.13% | 331.83M |
FQ2 2024 (Jun 2024) | -0.75 | -2.09259 | 4.164B | 6.87% | -3592M |
FQ1 2024 (Mar 2024) | -0.12 | -0.76 | 3.819B | 4.14% | -714.75M |
FQ4 2023 (Dec 2023) | 0.41 | 0.41 | 4.457B | 12.86% | 4457M |
FQ3 2023 (Sep 2023) | 0.07 | 0.07 | 3.85B | 6.62% | 3850M |
FQ2 2023 (Jun 2023) | -0.77 | -0.77 | 3.878B | 50.9% | 3878M |
FQ1 2023 (Mar 2023) | -0.18 | -0.18 | 3.661B | 100% | 3661M |
FQ4 Announce Date
03/30/2025 (Pre-Market)
Consensus EPS Estimates
0.5776
Consensus Revenue Estimates
3.8627222B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 0.74 | -- | 0.71907 | 0.76093 | 1 |
FQ2 2026 (Jun 2026) | 0.66 | -- | 0.64134 | 0.67867 | 1 |
FQ1 2026 (Mar 2026) | 0.585 | -- | 0.56094 | 0.60618 | 1 |
FQ4 2025 (Oct 2025) | 0.67577 | 128.12 | 0.65797 | 0.69319 | 3 |
FQ3 2025 (Jul 2025) | 0.65625 | 159.43 | 0.63897 | 0.67316 | 3 |
FQ2 2025 (Jun 2025) | 0.65623 | 214.29 | 0.63481 | 0.67562 | 3 |
FQ1 2025 (Mar 2025) | 0.5776 | 120.78 | 0.55875 | 0.59467 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 4.27B | -- | 4.17B | 4.36B | 2 |
FQ2 2026 (Jun 2026) | 4.11B | -- | 4.02B | 4.2B | 2 |
FQ1 2026 (Mar 2026) | 3.92B | -- | 3.8B | 4.03B | 2 |
FQ4 2025 (Oct 2025) | 4.06B | -4.14 | 3.98B | 4.14B | 2 |
FQ3 2025 (Jul 2025) | 4.11B | -5.34 | 4.03B | 4.19B | 2 |
FQ2 2025 (Jun 2025) | 4.11B | -1.25 | 4.01B | 4.21B | 2 |
FQ1 2025 (Mar 2025) | 3.86B | 1.13 | 3.77B | 3.95B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.62708 | -0.19 | -0.81708 | 430.04% |
FQ3 2024 (Sep 2024) | 0.58268 | -0.39 | -0.97268 | 249.41% |
FQ2 2024 (Jun 2024) | 1.34259 | -0.75 | -2.09259 | 279.01% |
FQ1 2024 (Mar 2024) | 0.64 | -0.12 | -0.76 | 633.33% |
FQ4 2023 (Dec 2023) | 0.41 | 0.41 | 100% | |
FQ3 2023 (Sep 2023) | 0.07 | 0.07 | 100% | |
FQ2 2023 (Jun 2023) | -0.77 | -0.77 | 100% | |
FQ1 2023 (Mar 2023) | -0.18 | -0.18 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $4.01B | $4.23B | $220.2M | 5.21% |
FQ3 2024 (Sep 2024) | $4B | $4.33B | $331.83M | 7.66% |
FQ2 2024 (Jun 2024) | $7.76B | $4.16B | $-3592M | -86.26% |
FQ1 2024 (Mar 2024) | $4.53B | $3.82B | $-714.75M | -18.72% |
FQ4 2023 (Dec 2023) | $0B | $4.46B | $4457M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.85B | $3850M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.88B | $3878M | 100% |
FQ1 2023 (Mar 2023) | $0B | $3.66B | $3661M | 100% |